345752 <common-name>[1-[(e)-[[2-(3-chloro-2-methylanilino)-2-oxoacetyl]hydrazinylidene]methyl]naphthalen-2-yl] 2,4-dichlorobenzoate</common-name> <description>[1-[(e)-[[2-(3-chloro-2-methylanilino)-2-oxoacetyl]hydrazinylidene]methyl]naphthalen-2-yl] 2,4-dichlorobenzoate is a chemical compound with the formula C27H18Cl3N3O4. With an average molecular weight of 554.80 g/mol, [1-[(e)-[[2-(3-chloro-2-methylanilino)-2-oxoacetyl]hydrazinylidene]methyl]naphthalen-2-yl] 2,4-dichlorobenzoate is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>51060373</pubchem-id> <chemical-formula>C27H18Cl3N3O4</chemical-formula> <weight>554.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T08:43:50Z</created-at> <updated-at type="dateTime">2026-08-31T08:43:50Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C=CC=C1Cl)NC(=O)C(=O)NN=CC2=C(C=CC3=CC=CC=C32)OC(=O)C4=C(C=C(C=C4)Cl)Cl</moldb-smiles> <moldb-formula>C27H18Cl3N3O4</moldb-formula> <moldb-inchi>InChI=1S/C27H18Cl3N3O4/c1-15-21(29)7-4-8-23(15)32-25(34)26(35)33-31-14-20-18-6-3-2-5-16(18)9-12-24(20)37-27(36)19-11-10-17(28)13-22(19)30/h2-14H,1H3,(H,32,34)(H,33,35)/b31-14+</moldb-inchi> <moldb-inchikey>CWQODXKDIUQZTI-XAZZYMPDSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">553.036289</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM341645</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>[1-[(e)-[[2-(3-chloro-2-methylanilino)-2-oxoacetyl]hydrazinylidene]methyl]naphthalen-2-yl] 2,4-dichlorobenzoate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0296107</sync-id> <structure-inchikey>CWQODXKDIUQZTI-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>1080000200000000000040000400000000100080000000080000000000000202000000024002000000000020000040000000000000000000000000000008400000000000000000000020000000000300000004000000000000000000010080000000000080100000000000080000000000020000000000000001000040000001800080000000001080000000000100600080000000000000000000080200000000040000082000000000000000000000000000008000000000000000040100000000000000000080000010008000002040000200002000000000008000000001001040000000000400000000000020000100000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMGQCgAAAAD BAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQR ACAAAAABBwBoAAAAAwIBBgAoAAAAAwQIACgAAAADAgYAKAAAAAMECAAoAAAA AwIHAGgAAAADAgEHACgAAAADAwYAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQG QGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA aAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMECAAoAAAAAwIGACgAAAADBAgAKAAA AAMCBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMB BkBoAAAAAwMBEQAgAAAAAREAIAAAAAELAAEAAQJoDAIDaAwDBGgMBAVoDAUG aAwGBwACCCAICSAJCigCCQsgCwwoAgsNIA0OIA4PKAIPECAQEWgMERJoDBIT aAwTFGgMFBVoDBUWaAwWF2gMFxhoDBgZaAwRGiAaGyAbHCgCGx0gHR5oDB4f aAwfIGgMICFoDCEiaAwgIwAeJAAGAWgMGRBoDBkUaAwiHWgMQgQAAAAGAQYF BAMCBhITFBkQEQYVFhcYGRQGHh8gISIdFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:42Z</structure-indexed-at> </compound>